Trained Neuroscientist Brings Vast Experience in Business Development and Preclinical Research to Accelerate Company Efforts in Developing Next-Generation Psychedelic Medicines TORONTO, Feb. 08, 2022 (GLOBE NEWSWIRE) — Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF) (“Mindset” or the “Company”), a drug discovery and development company focused on creating optimized and patentable next…
